Cargando…

Vicious cycle between severity of childhood obesity and pandemic: Potential impact of metformin

INTRODUCTION: COVID-19 is currently a global pandemic, and initial reports of identified COVID-19 lockdown and limitations can adversely affect childhood obesity and metabolic health. Studies conducted in recent years have shown that the rate of obesity in childhood increases with the changing lifes...

Descripción completa

Detalles Bibliográficos
Autores principales: Samur, Bahadir M., Samur, Tugba G., Gul-Sir, Ulku, Hatipoglu, Nihal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190200/
https://www.ncbi.nlm.nih.gov/pubmed/35720680
http://dx.doi.org/10.1016/j.obmed.2022.100433
_version_ 1784725741340983296
author Samur, Bahadir M.
Samur, Tugba G.
Gul-Sir, Ulku
Hatipoglu, Nihal
author_facet Samur, Bahadir M.
Samur, Tugba G.
Gul-Sir, Ulku
Hatipoglu, Nihal
author_sort Samur, Bahadir M.
collection PubMed
description INTRODUCTION: COVID-19 is currently a global pandemic, and initial reports of identified COVID-19 lockdown and limitations can adversely affect childhood obesity and metabolic health. Studies conducted in recent years have shown that the rate of obesity in childhood increases with the changing lifestyle with the pandemic. However, there is insufficient data on how the situation changes and how metabolism is affected in those, who are already obese. The aim of this paper was to determine how the pandemic affects the current status, severity, and metabolic parameters of obese children. We also attempted to show potential effects of metformin therapy. METHODS: The study was conducted with the participation of 101 patients with obesity (The mean age was 13.6 ± 2.2). The patients were evaluated using pre- and post-lockdown data with an interval of 6 months. The new classification system was used to determine the severity of obesity. All anthropometrics, metabolic parameters (Blood glucose, insulin, HbA1C, lipid profile), lifestyle, and comorbidities were evaluated by dividing the participants into various subgroups according to their obesity and metformin usage status. RESULTS: Our data shows that weight, height, BMI, BMI-SD, and BMI percentiles all increased significantly, after the pandemic started. The severity of obesity increased statistically (overweight decreases and class 2 obesity increases, p = 0.001). No change was observed in metabolic parameters. Surprisingly, a significant increase was observed in insulin and HOMA-IR values in the group with-metformin. DISCUSSION: Most studies about childhood obesity have only focused on obesity increases and pandemic relation. Our study showed that although there was no significant change in metabolic status at the end of a lockdown period, there was a serious increase in the severity of obesity. Metformin use had no effect on either obesity or metabolic parameters, and even an increase in insulin resistance indicators was observed.
format Online
Article
Text
id pubmed-9190200
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-91902002022-06-13 Vicious cycle between severity of childhood obesity and pandemic: Potential impact of metformin Samur, Bahadir M. Samur, Tugba G. Gul-Sir, Ulku Hatipoglu, Nihal Obes Med Article INTRODUCTION: COVID-19 is currently a global pandemic, and initial reports of identified COVID-19 lockdown and limitations can adversely affect childhood obesity and metabolic health. Studies conducted in recent years have shown that the rate of obesity in childhood increases with the changing lifestyle with the pandemic. However, there is insufficient data on how the situation changes and how metabolism is affected in those, who are already obese. The aim of this paper was to determine how the pandemic affects the current status, severity, and metabolic parameters of obese children. We also attempted to show potential effects of metformin therapy. METHODS: The study was conducted with the participation of 101 patients with obesity (The mean age was 13.6 ± 2.2). The patients were evaluated using pre- and post-lockdown data with an interval of 6 months. The new classification system was used to determine the severity of obesity. All anthropometrics, metabolic parameters (Blood glucose, insulin, HbA1C, lipid profile), lifestyle, and comorbidities were evaluated by dividing the participants into various subgroups according to their obesity and metformin usage status. RESULTS: Our data shows that weight, height, BMI, BMI-SD, and BMI percentiles all increased significantly, after the pandemic started. The severity of obesity increased statistically (overweight decreases and class 2 obesity increases, p = 0.001). No change was observed in metabolic parameters. Surprisingly, a significant increase was observed in insulin and HOMA-IR values in the group with-metformin. DISCUSSION: Most studies about childhood obesity have only focused on obesity increases and pandemic relation. Our study showed that although there was no significant change in metabolic status at the end of a lockdown period, there was a serious increase in the severity of obesity. Metformin use had no effect on either obesity or metabolic parameters, and even an increase in insulin resistance indicators was observed. Elsevier Ltd. 2022-08 2022-06-13 /pmc/articles/PMC9190200/ /pubmed/35720680 http://dx.doi.org/10.1016/j.obmed.2022.100433 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Samur, Bahadir M.
Samur, Tugba G.
Gul-Sir, Ulku
Hatipoglu, Nihal
Vicious cycle between severity of childhood obesity and pandemic: Potential impact of metformin
title Vicious cycle between severity of childhood obesity and pandemic: Potential impact of metformin
title_full Vicious cycle between severity of childhood obesity and pandemic: Potential impact of metformin
title_fullStr Vicious cycle between severity of childhood obesity and pandemic: Potential impact of metformin
title_full_unstemmed Vicious cycle between severity of childhood obesity and pandemic: Potential impact of metformin
title_short Vicious cycle between severity of childhood obesity and pandemic: Potential impact of metformin
title_sort vicious cycle between severity of childhood obesity and pandemic: potential impact of metformin
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190200/
https://www.ncbi.nlm.nih.gov/pubmed/35720680
http://dx.doi.org/10.1016/j.obmed.2022.100433
work_keys_str_mv AT samurbahadirm viciouscyclebetweenseverityofchildhoodobesityandpandemicpotentialimpactofmetformin
AT samurtugbag viciouscyclebetweenseverityofchildhoodobesityandpandemicpotentialimpactofmetformin
AT gulsirulku viciouscyclebetweenseverityofchildhoodobesityandpandemicpotentialimpactofmetformin
AT hatipoglunihal viciouscyclebetweenseverityofchildhoodobesityandpandemicpotentialimpactofmetformin